Sign In
Buy GERM
$19.16
+0 (+0%)
At Close: Dec 04, 2024
Amplify ETFs to Liquidate Three ETFs
08:15am, Wednesday, 14'th Aug 2024
CHICAGO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Amplify ETFs, a leading provider of exchange traded funds, today announced the scheduled liquidation of three ETFs (the “Funds”). The Funds scheduled for
Finding Opportunity in Unloved Healthcare ETFs
11:02am, Friday, 31'st May 2024
Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?
Amplify's Christian Magoon on Purchase of ETFMG's ETFs
06:11pm, Tuesday, 29'th Aug 2023
In June, the ETF industry learned that issuer ETF Managers Group would be selling its funds to Amplify ETFs. The transaction, once completed, will bring Amplify's total AUM to $8 billion invested acro
This Week in ETFs: A Summer Slowdown
07:26pm, Friday, 21'st Jul 2023
The week ending Friday, July 21, has been busy for the ETF industry, though launches were muted. A total of seven funds rolled out, which suggests the market could be entering some kind of summer slum
Biotech ETFs in Focus on Covid Vaccines' Fall Rollout
03:37pm, Thursday, 22'nd Jun 2023
The FDA advised to Pfizer, Moderna and Novavax to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5 should prove to be a victory for some biotech ETFs.
Can Health Care Stocks Outperform Again In 2023?
06:09pm, Wednesday, 11'th Jan 2023
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
Here's Why COVID-Themed ETFs May Come Back Under the Radar
02:18pm, Wednesday, 26'th Oct 2022
COVID-themed stocks and ETFs were winners in 2020 and some parts of 2021 due to a spike in global coronavirus cases. We may see the same trend again as new COVID variants are 'pretty troublesome.
Biotech ETFs Slip After Novavax Cuts 2022 Guidance
08:39am, Thursday, 11'th Aug 2022
Biotechnology sector-related exchange traded funds retreated with Novavax Inc. (NasdaqGS: NVAX), plunging after the vaccine developer cut its 2022 revenue guidance in half. On Tuesday, the iShares Gen
Moderna Q2 Earnings, Buyback Plans Lift Biotech ETFs
06:23pm, Wednesday, 03'rd Aug 2022
Moderna Inc (NasdaqGS: MRNA) shares surged Wednesday, lifting biotechnology sector-related exchange traded funds, after the pharmaceutical company revealed better-than-expected profit and revenue in i
Pharma & Biotech ETFs at One-Month High: Here's Why
09:20am, Friday, 08'th Jul 2022
Pharma and biotech ETFs are in great shape and are trading at a one-month high level.
Vir Jumps 20% On S&P SmallCap 600 News
12:25pm, Thursday, 31'st Mar 2022
Currently, 66 ETFs are affected, but it will be added to even more funds soon.
China ETFs Drop On Audit Enforcement
03:03pm, Friday, 11'th Mar 2022
The first tranche of Chinese ADRs affected by a 2020 law has been released.
Biotech ETFs That Outperformed Last Week
01:46pm, Monday, 20'th Dec 2021
Biotech ETFs was the biggest gainer last week.
Healthcare Emerges as Best Sector of Last Week: 5 Top ETFs
09:13am, Monday, 20'th Dec 2021
Wall Street was downbeat last week with all indexes in the red. Still, Healthcare sector emerged as a key winner last week.
5 Best Sector ETFs of November
11:30am, Wednesday, 01'st Dec 2021
Though the broad markets ended the month in red, a few sector ETFs performed remarkably well.
